Kenneth Warrington Jr.

Kenneth Warrington Jr. is a scientific advisor at Lacerta Therapeutics. Kenneth has also worked as the senior vice president of operations and business development at BioStem Life Sciences, the chief technology officer at Lacerta Therapeutics, and a business development manager-cell & gene therapy at WuXi AppTec. Warrington has also served as a director of business development at inVentiv Health Clinical and as a biosafety business development director, North America at SGS. Kenneth's other positions include biopharmaceutical specialist and adjunct professor of biology.

Kenneth Warrington Jr. completed a BS in Biology/Chemistry at St. Lawrence University. Kenneth then went on to do a Graduate Program in Environmental Medicine-Toxicology at the University of Rochester School of Medicine and Dentistry. Lastly, they obtained their Ph.D. in Pharmacology and Experimental Therapeutics from the University of Florida.